Annual gross profit:
$453.46M+$86.63M(+23.61%)Summary
- As of today (September 16, 2025), RARE annual gross profit is $453.46 million, with the most recent change of +$86.63 million (+23.61%) on December 31, 2024.
- During the last 3 years, RARE annual gross profit has risen by +$131.30 million (+40.76%).
- RARE annual gross profit is now at all-time high.
Performance
RARE Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$134.88M+$33.23M(+32.70%)Summary
- As of today (September 16, 2025), RARE quarterly gross profit is $134.88 million, with the most recent change of +$33.23 million (+32.70%) on June 30, 2025.
- Over the past year, RARE quarterly gross profit has increased by +$17.99 million (+15.39%).
- RARE quarterly gross profit is now -2.90% below its all-time high of $138.90 million, reached on December 31, 2024.
Performance
RARE quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$485.13M+$17.99M(+3.85%)Summary
- As of today (September 16, 2025), RARE TTM gross profit is $485.13 million, with the most recent change of +$17.99 million (+3.85%) on June 30, 2025.
- Over the past year, RARE TTM gross profit has increased by +$83.39 million (+20.76%).
- RARE TTM gross profit is now at all-time high.
Performance
RARE TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
RARE Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.6% | +15.4% | +20.8% |
| 3 y3 years | +40.8% | +74.5% | +62.6% |
| 5 y5 years | +426.3% | +137.8% | +239.3% |
RARE Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.7% | -2.9% | +74.5% | at high | +62.6% |
| 5 y | 5-year | at high | +426.3% | -2.9% | +137.8% | at high | +239.3% |
| alltime | all time | at high | >+9999.0% | -2.9% | >+9999.0% | at high | >+9999.0% |
RARE Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $134.88M(+32.7%) | $485.13M(+3.9%) |
| Mar 2025 | - | $101.64M(-26.8%) | $467.14M(+4.3%) |
| Dec 2024 | $453.46M(+23.6%) | $138.90M(+26.6%) | $447.96M(+5.6%) |
| Sep 2024 | - | $109.72M(-6.1%) | $424.40M(+5.6%) |
| Jun 2024 | - | $116.88M(+41.8%) | $401.75M(+4.8%) |
| Mar 2024 | - | $82.45M(-28.5%) | $383.26M(-0.3%) |
| Dec 2023 | $366.83M(+14.6%) | $115.34M(+32.5%) | $384.50M(+5.8%) |
| Sep 2023 | - | $87.06M(-11.5%) | $363.33M(+2.5%) |
| Jun 2023 | - | $98.39M(+17.6%) | $354.35M(+6.3%) |
| Mar 2023 | - | $83.70M(-11.1%) | $333.25M(+4.1%) |
| Dec 2022 | $320.01M(-0.7%) | $94.17M(+20.6%) | $319.99M(+5.9%) |
| Sep 2022 | - | $78.08M(+1.0%) | $302.16M(+1.3%) |
| Jun 2022 | - | $77.29M(+9.7%) | $298.34M(-1.1%) |
| Mar 2022 | - | $70.45M(-7.7%) | $301.77M(-6.3%) |
| Dec 2021 | $322.16M(+27.5%) | $76.35M(+2.8%) | $322.16M(-2.0%) |
| Sep 2021 | - | $74.25M(-8.0%) | $328.74M(-0.5%) |
| Jun 2021 | - | $80.72M(-11.1%) | $330.52M(+7.8%) |
| Mar 2021 | - | $90.84M(+9.5%) | $306.52M(+21.3%) |
| Dec 2020 | $252.64M(+193.2%) | $82.93M(+9.1%) | $252.64M(+27.6%) |
| Sep 2020 | - | $76.03M(+34.0%) | $198.03M(+38.5%) |
| Jun 2020 | - | $56.72M(+53.5%) | $142.97M(+33.0%) |
| Mar 2020 | - | $36.96M(+30.5%) | $107.53M(+24.8%) |
| Dec 2019 | $86.17M(+179.7%) | $28.32M(+35.0%) | $86.17M(+21.9%) |
| Sep 2019 | - | $20.97M(-1.4%) | $70.66M(+24.4%) |
| Jun 2019 | - | $21.28M(+36.4%) | $56.82M(+34.9%) |
| Mar 2019 | - | $15.60M(+21.8%) | $42.12M(+36.7%) |
| Dec 2018 | $30.81M | $12.81M(+79.6%) | $30.81M(+72.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $7.13M(+8.6%) | $17.90M(+66.3%) |
| Jun 2018 | - | $6.57M(+53.1%) | $10.76M(+243.2%) |
| Mar 2018 | - | $4.29M(-4349.5%) | $3.14M(-235.3%) |
| Dec 2017 | -$3.21M(<-9900.0%) | -$101.00K(<-9900.0%) | -$2.32M(+4.6%) |
| Sep 2017 | - | $0.00(-100.0%) | -$2.22M(0.0%) |
| Jun 2017 | - | -$1.05M(-9.1%) | -$2.22M(+90.9%) |
| Mar 2017 | - | -$1.16M(<-9900.0%) | -$1.16M(+113.4%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) | -$544.00K(-46.9%) |
| Sep 2016 | - | $0.00(0.0%) | -$1.02M(-30.1%) |
| Jun 2016 | - | $0.00(-100.0%) | -$1.47M(-15.2%) |
| Mar 2016 | - | -$544.00K(+13.3%) | -$1.73M(+24.8%) |
| Dec 2015 | -$1.38M(+102.3%) | -$480.00K(+8.8%) | -$1.38M(+24.0%) |
| Sep 2015 | - | -$441.00K(+68.3%) | -$1.12M(+28.4%) |
| Jun 2015 | - | -$262.00K(+30.3%) | -$869.00K(+13.2%) |
| Mar 2015 | - | -$201.00K(-5.2%) | -$768.00K(+12.3%) |
| Dec 2014 | -$684.00K(+54.1%) | -$212.00K(+9.3%) | -$684.00K(+17.1%) |
| Sep 2014 | - | -$194.00K(+20.5%) | -$584.00K(+18.0%) |
| Jun 2014 | - | -$161.00K(+37.6%) | -$495.00K(+48.2%) |
| Mar 2014 | - | -$117.00K(+4.5%) | -$334.00K(-2.1%) |
| Dec 2013 | -$444.00K(+41.9%) | -$112.00K(+6.7%) | -$341.00K(+6.2%) |
| Sep 2013 | - | -$105.00K(<-9900.0%) | -$321.00K(+4.2%) |
| Jun 2013 | - | $0.00(-100.0%) | -$308.00K(0.0%) |
| Mar 2013 | - | -$124.00K(+34.8%) | -$308.00K(+67.4%) |
| Dec 2012 | -$313.00K(+820.6%) | -$92.00K(0.0%) | -$184.00K(+100.0%) |
| Sep 2012 | - | -$92.00K(<-9900.0%) | -$92.00K(<-9900.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | -$34.00K | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual gross profit?
- What is the all time high annual gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual gross profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly gross profit?
- What is the all time high quarterly gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly gross profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM gross profit?
- What is the all time high TTM gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM gross profit year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual gross profit?
The current annual gross profit of RARE is $453.46M
What is the all time high annual gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual gross profit is $453.46M
What is Ultragenyx Pharmaceutical Inc. annual gross profit year-on-year change?
Over the past year, RARE annual gross profit has changed by +$86.63M (+23.61%)
What is Ultragenyx Pharmaceutical Inc. quarterly gross profit?
The current quarterly gross profit of RARE is $134.88M
What is the all time high quarterly gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly gross profit is $138.90M
What is Ultragenyx Pharmaceutical Inc. quarterly gross profit year-on-year change?
Over the past year, RARE quarterly gross profit has changed by +$17.99M (+15.39%)
What is Ultragenyx Pharmaceutical Inc. TTM gross profit?
The current TTM gross profit of RARE is $485.13M
What is the all time high TTM gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM gross profit is $485.13M
What is Ultragenyx Pharmaceutical Inc. TTM gross profit year-on-year change?
Over the past year, RARE TTM gross profit has changed by +$83.39M (+20.76%)